Romiplostim biosimilar (Intas Pharmaceuticals)
罗米司亭生物类似药 (Intas Pharmaceuticals)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRomiplostim biosimilar (Intas Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesIntas Biopharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesIntas Biopharmaceuticals
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A